Join our Solid Cancer Observatory
Use real-world data (RWD) to monitor treatment pathways of patients with conditions in this field to evaluate the standard of care, clinical effectiveness and associated costs of different treatment paths.
Actionable insights into drug use and effectiveness
Gain insights into the uptake of a specific drug, the use of a specific drug in patient pathways, and the effectiveness of the drug in a standardised manner.
Hospitals participate burden free
We run treatment improvement projects that are easy to join. They are, by design, completely compliant with all legal requirements around ethics, data security, and privacy.
.jpeg?width=5894&height=3935&name=AdobeStock_315674262%20(2).jpeg)
Unlocking the value of RWD
By enabling the use of real-world data that reflect the actual population treated, it is possible to assess the treatment effects of (new) oncology treatments. This makes timely decision-making easy and evidence-driven.
Data granularity
The level of detail LOGEX has access to is unique, allowing exceptional visibility into patient pathways. E.g.:
- Patient pathway mapping
- Lines of treatment
- Combinations of drugs and indication split
- Filter on specific patient groups
Data access & recency
Longitudinal insights
Scalability
The observatory setup allows for quick expansion into related disease areas under the same contracts.
With our extensive network of hospitals across Europe, expanding into other countries is highly feasible.
Experience
LOGEX has over 10 years of experience working with 700+ healthcare providers across the EU.
We are experts in extracting, delivering, validating and analysing healthcare datasets in close collaboration with HCPs.
Security by design
NEN7510 and ISO27001 certified, full compliance with GDPR.
FG and security officers, authorisation levels, two-factor authentication, informed / explicit consent.
Patient Engagement
Optimise digital patient engagement activities while collecting valuable data.
Financial Analytics
Controlling costs and optimising operations through data-driven decision-making.
How we helped hospitals and Janssen to personalise the treatment pathways of prostate cancer patients through the TripleAiM1 project
Actionable insights into innovative medicines and their costs
Report: "On the Horizon".
March 2024 edition.
Solidifying Oncology Drug Effectiveness After Approval with Real-World Evidence
A Data-Driven Analysis of Care Pathways for Oncological Patients with Bone Metastases at HagaZiekenhuis
-1.jpg?width=1732&height=1155&name=Stocksy_txp3c7f9c9dMmT300_Medium_2944384-edit%20(1)-1.jpg)
How can RWE be used to solve unwarranted variation in drug uptake and clinical guidelines?
Get clarity and control to make better decisions.
Do you have any questions about harnessing data-driven insights for better decision-making? Allow our experts, such as Sarah, to lead the way.
We will reply within two business days.
